Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Invion ( (AU:IVX) ) just unveiled an update.
Invion Limited has announced a proposed issue of securities, specifically options expiring on June 30, 2027, with a maximum of 1,564,508 securities to be issued. This move is part of a placement or other type of issue, and the proposed issue date is November 28, 2025. The announcement signifies Invion’s strategic efforts to enhance its financial position and potentially expand its operations, which could impact its market positioning and stakeholder interests.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is known for its innovative approach to addressing unmet medical needs through its research and development efforts.
Average Trading Volume: 112,655
Technical Sentiment Signal: Sell
Current Market Cap: A$8.56M
Find detailed analytics on IVX stock on TipRanks’ Stock Analysis page.